Evidence Level
Ashwagandha is a well-researched adaptogen with substantial evidence supporting its benefits for stress, anxiety, sleep, and cognitive function. A 2019 meta-analysis published in the Journal of Alternative and Complementary Medicine analyzed five randomized controlled trials and found significant reductions in stress and anxiety scores following Ashwagandha supplementation (Pratte et al., 2014). The most studied extract, KSM-66, has been evaluated in over 22 clinical trials, demonstrating its efficacy across multiple health domains.
Recent studies further corroborate these findings. A systematic review and meta-analysis by Alsanie et al. (2026) analyzed 22 randomized controlled trials, confirming Ashwagandha's role in reducing stress and anxiety. Similarly, Arumugam et al. (2024) conducted a systematic review of nine randomized controlled trials involving 558 participants, concluding that Ashwagandha significantly lowers cortisol levels and alleviates symptoms of stress and anxiety compared to placebo.
In addition to its anxiolytic effects, Ashwagandha has been shown to improve sleep quality. Cheah et al. (2021) reviewed five randomized controlled trials involving 400 participants and found that Ashwagandha extract significantly enhanced sleep outcomes in adults. Furthermore, Ng et al. (2020) conducted a systematic review of five clinical trials, highlighting its potential to ameliorate cognitive dysfunction.
Overall, the evidence supports Ashwagandha as a valuable natural intervention for managing stress-related conditions and promoting overall well-being.